QTc prolongation and mortality in SARS-2-CoV-infected patients treated with azithromycin and hydroxychloroquine

J Cardiovasc Med (Hagerstown). 2022 Jan 1;23(1):e21-e23. doi: 10.2459/JCM.0000000000001238.

Enrico Baldi^{1

2}, Roberto Rordorf¹, Lucrezia Masiello^{1

2}, Sabato D'Amore^{1

2}, Stefano Ghio³, Elena Maria Seminari⁴, Federica Melazzini⁵, Elia Fraolini⁶, Stefano Perlini^{7

5}, Guido Tavazzi^{8

9}, Alessandro Vicentini¹

¹ Cardiac Intensive Care Unit, Arrhythmia and Electrophysiology & Laboratory of Clinical & Experimental Cardiology, Fondazione IRCCS Policlinico San Matteo.
² Department of Molecular Medicine, Cardiology Unit, University of Pavia.
³ Division of Cardiology, Fondazione IRCCS Policlinico San Matteo.
⁴ Division of Infectious Disease.
⁵ Department of Internal Medicine.
⁶ Division of Respiratory Diseases, Fondazione IRCCS Policlinico San Matteo & University of Pavia, Italy.
⁷ Emergency Department, Fondazione IRCCS Policlinico San Matteo.
⁸ Department of Clinical-Surgical, Diagnostic & Pediatric Sciences, Unit of Anesthesia & Intensive Care, University of Pavia.
⁹ Anaesthesia and Intensive Care, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

No abstract available

Publication types